Senator Jim Banks (R-Ind.) introduced the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act. The bill would strengthen existing guardrails and close loopholes in the Food, Drug, and Cosmetic Act to stop unapproved compounders from mass-producing risky drugs in unregulated and uninspected facilities.
I will work to strengthen guardrails and close loopholes in the Food, Drug, and Cosmetic Act to stop unapproved compounders from mass-producing risky drugs in unregulated and uninspected facilities.
Occurrences
Evidence
This week, Senator Jim Banks (R-Ind.) introduced the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act. The bill would strengthen existing guardrails and close loopholes in the Food, Drug, and Cosmetic Act to stop unapproved compounders from mass-producing risky drugs in unregulated and uninspected facilities.
Sponsor: Sen. Banks, Jim [R-IN] (Introduced 02/05/2026). Latest Action: Senate - 02/05/2026 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. This bill has the status Introduced.
Assessments
Banks made a concrete same-term legislative effort by introducing S.3794, the SAFE Drugs Act, on February 5, 2026, to amend the Food, Drug, and Cosmetic Act and further regulate compounding pharmacies and outsourcing facilities. However, Congress.gov shows the bill remains only introduced and referred to the Senate HELP Committee, with no passage or enactment. Because the promised outcome was to strengthen guardrails and close loopholes, not merely introduce legislation, the outcome has not been delivered, but the effort badge is warranted.